Healthcare EquitiesNovo Nordisk Stock Up 24.9% in 30 Days as AI Restructuring Sharpens GLP-1 FocusSalvado•Jun 5, 2026
Sector ConsolidationEli Lilly Tops $20B in 2026 Acquisitions, Betting AI Compresses Drug Development TimelinesSalvado•May 31, 2026
Biotech EquitiesNovo Nordisk's 24.9% Rally Bets on AI-Driven Pipeline Over In-House BiologySalvado•May 31, 2026
Pharma/Biotech StocksNovo Nordisk Jumps 24.9% in 30 Days as AI Drug Pipelines Win Market ConfidenceSalvado•May 27, 2026
Tech & Healthcare EarningsNVIDIA BioNeMo Wins Lilly, Thermo Fisher as AI Drug Discovery Shifts to Production ScaleSalvado•Apr 18, 2026
Technology StocksNVIDIA Expands Beyond GPUs with BioNeMo Platform, Partnering Eli Lilly and Thermo Fisher for AI Drug DiscoverySalvado•Apr 13, 2026
Technology StocksNVIDIA BioNeMo Platform Adoption Accelerates as Eli Lilly, Thermo Fisher Deploy AI Drug Discovery InfrastructureSalvado•Apr 10, 2026
Healthcare SectorAI Biotech Clinical Pipelines Target 2026-2027 Commercialization as Wave Life Sciences Reports Body Composition DataSalvado•Mar 28, 2026
